tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
PremiumThe FlyApple initiated, Hershey upgraded: Wall Street’s top analyst calls
18d ago
Camp4 Therapeutics downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Camp4 Therapeutics downgraded to Neutral from Overweight at JPMorgan
18d ago
Camp4 Therapeutics price target lowered to $12 from $18 at Piper Sandler
Premium
The Fly
Camp4 Therapeutics price target lowered to $12 from $18 at Piper Sandler
19d ago
CAMP4 Therapeutics Reports Q2 2025 Progress and Outlook
PremiumCompany AnnouncementsCAMP4 Therapeutics Reports Q2 2025 Progress and Outlook
1M ago
Promising Pipeline Developments Drive Buy Rating for CAMP4 Therapeutics
Premium
Ratings
Promising Pipeline Developments Drive Buy Rating for CAMP4 Therapeutics
2M ago
Promising Potential and Strategic Growth: Buy Rating for CAMP4 Therapeutics
Premium
Ratings
Promising Potential and Strategic Growth: Buy Rating for CAMP4 Therapeutics
2M ago
CAMP4 Therapeutics Unveils Promising Data at ASGCT 2025
PremiumCompany AnnouncementsCAMP4 Therapeutics Unveils Promising Data at ASGCT 2025
5M ago
Camp4 Therapeutics delivers three presentantions on SYNGAP1-related disorders
Premium
The Fly
Camp4 Therapeutics delivers three presentantions on SYNGAP1-related disorders
5M ago
CAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
Premium
Ratings
CAMP4 Therapeutics: Promising Pipeline and Strong Financials Justify Buy Rating
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100